The U.S.-Sweden Technology Prosperity Deal has opened a new chapter for transatlantic collaboration in life sciences, with implications for trade, investment, innovation and long-term industry partnerships between the two countries.

AmCham Sweden and MSD welcome you to an exclusive breakfast seminar exploring how this momentum can translate into real growth for the biotech sector. The morning opens with remarks by Viraj LeBailly, Deputy Chief of Mission at the U.S. Embassy Stockholm, followed by a discussion with Olof Akre, Head of R&D, Karolinska University Hospital; Peter Dahlen, Managing Director, AmCham Sweden; and Birgitta Wikman Erlandson, Managing Director, MSD Sweden. Together, they will share policy and industry perspectives on how Sweden and the U.S. can attract new investment, accelerate innovation, and deepen transatlantic life science ties.

Agenda:

8:00 - Arrival and breakfast
8:15 - Welcome and Introductions
8:20 - Opening remarks by Viraj LeBailly, Deputy Chief of Mission, U.S. Embassy Stockholm
8:30 - Panel Discussion
9:15 - Q&A
9:30 - End of Program

Powered by:

(Invitations have been Distributed to AmCham Members)